Details of the Drug

General Information of Drug (ID: DMA18BH)

• Drug Name: FT500

Indication

Disease Entry	ICD 11	Status	REF
Acute myeloid leukaemia	2A60	Phase 1	[1]
B-cell lymphoma	2A86	Phase 1	[1]

• Drug Type: Cell therapy
• Cross-matching ID: TTD ID: DSYM73
• Repurposed Drugs (RPD): Click to Jump to the Detailed RPD Information of This Drug

References

• [1] ClinicalTrials.gov (NCT03841110) FT500 as Monotherapy and in Combination With Immune Checkpoint Inhibitors in Subjects With Advanced Solid Tumors. U.S. National Institutes of Health.